EP3390389
POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS
:
EP einkaleyfi: Þýðing ekki lögð inn:
16.12.2016:
19.5.2021:
16840344.2
:
15.12.2036
:
POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS
16.12.2016
19.5.2021
:
Merck Patent GmbH:
Frankfurter Strasse 250, 64293 Darmstadt, DE
:
SHERER, Brian A.:
Nashua New Hampshire 03062, US
:
BRUGGER, Nadia:
Cambridge Massachusetts 02140, US
:
201562268765 P:
17.12.2015:
US
:
201662353603 P:
23.6.2016:
US
:
US2016067112:
16.12.2016
:
C07D 401/14, C07D 405/14, C07D 413/14, C07D 401/04, C07D 413/04, C07D 417/04, C07D 241/42, C07D 471/04, C07D 487/04, A61K 31/4375, A61P 37/00